Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> White House Panel Backs Accelerated Drug Reviews
FDAnews Drug Daily Bulletin
Sept. 28, 2012
| Vol. 9 No. 191
White House Panel Backs Accelerated Drug Reviews
The United States can double the number of innovative new medical treatments available in the next 10 or 15 years, but only if important changes are made to how drugs are developed and approved, according to a White House report.
Science Magazine
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Pharma Blog Watch
Drug Prices to Increase By 10 Percent
Enbrel and the Autoimmune Era
Briefs